Another promising shot treats two of the deadliest and
fastest-rising forms of the disease, early study shows
fastest-rising forms of the disease, early study shows
A phase 1, first-in-human trial presented at a cancer conference
in Chicago this weekend showed that an off-the-shelf vaccine in development lowered the risk of relapse in patients with colon and pancreatic cancer.
It does this by using amino acid chains called peptides to attack the KRAS mutation in the cancers. All patients in the trial saw an immune response with few minor side effects.
Additional trials are needed, but the researchers are hopeful this could improve survival of two of the deadliest and fastest-rising forms of the disease.
The full report can be found here:
...
I think you know she'd like this,
so go ahead and get it for her...
The bracelet is only $ 38.00 and that includes free shipping.
Click on the picture for more information.
...
THe real question is, would you believe them when they say they have a cancer vaccination?
ReplyDeleteOr, at this point, a vaccination for anything?
CC
"More studies are needed".
ReplyDeleteNah, just force everybody to get the shot and find out.
"Follow the science".
Given that the latest "vaccine" appears to both cause cancers by destroying the immune system and cause cancers in "remission" to come back as "turbo cancer" as oncologists are calling it, I wouldn't get my hopes up about anything coming from the murderers at bigPharma. Instead, I would be beyond skeptical and suspect that any new shot is actually designed to inflict even more death than the mRNA jabs were designed to inflict.
ReplyDelete